Research advances in association between Toll- like receptor 4 and hepatitis B
-
摘要:
Toll样受体(TLR)4是一种重要的模式识别受体,在抑制HBV感染中发挥着重要的作用。TLR4识别HBV相关蛋白分子,经髓系分化因子88(My D88)和非My D88途径,产生肿瘤坏死因子α、白细胞介素(IL)6、IL-12等炎症因子和Ⅰ型干扰素而发挥抗病毒作用。同时发现TLR4可通过调节辅助性T淋巴细胞(Th)1与Th2间的平衡,促进CD8+T淋巴细胞在肝脏粘附及诱导一氧化氮合酶发挥抑制HBV作用。若TLR4过表达,会通过机体免疫系统过度激活,加重肝脏的缺血再灌注及肝星状细胞激活而加重肝脏炎症。回顾了国内外近年相关文献,探讨了TLR4在乙型肝炎发病中的相关机制,总结了TLR4与乙型肝炎的相关性,以期通过TLR4与乙型肝炎相关性的研究,发现治疗乙型肝炎及延缓其向肝硬化和肝癌进展的新方案。
Abstract:Toll- like receptor 4( TLR4) is an important pattern recognition receptor and plays an important role in the inhibition of hepatitis B virus( HBV) infection. It identifies the HBV- related proteins and produces inflammatory factors,such as tumor necrosis factor- α,interleukin- 6,and interleukin- 12,and type I interferon through the myeloid differentiation factor 88( My D88) and the non- My D88 pathway,and thus TLR4 exerts its antiviral effect. Meanwhile,it has been found that TLR4 regulates the balance between T helper 1 and T helper 2 cells,promotes the adhesion of CD8+T lymphocytes in the liver,induces the secretion of inducible nitric oxide synthase,and thus inhibits HBV. If overexpressed,TLR4 will aggravate liver inflammation by excessively activating the body's immune system,aggravating liver ischemia / reperfusion,and activating hepatic stellate cells. This article reviews related articles published at home and abroad in recent years,discusses the mechanisms of action of TLR4 in the pathogenesis of hepatitis B,and summarizes the association between TLR4 and hepatitis B,in order to find new therapies for hepatitis B and new protocols which delay the progression of hepatitis B to liver cirrhosis and liver cancer through the studies on the association between TLR4 and hepatitis B.
-
Key words:
- hepatitis B /
- Toll-like receptor 4 /
- review
-
[1]DING SL,WANG J,LU FM.Current status of research on hepatitis B and its prevention and treatment in China[J].Infect Dis Info,2013,26(6):369-372.(in Chinese)丁善龙,王杰,鲁凤民.乙型肝炎研究及我国防治现状[J].传染病信息,2013,(6):369-372. [2]ZHANG Y,QU J,ZHANG J.The effects of TLR4 activation on the characterizations of digestive system associated cancers[J].Chin J Immun,2012,28(8):695-700. [3]GUO J,FRIEDMAN SL.Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis[J].Fibrogenesis Tissue Repair,2010,3:21. [4]ZHANG S,YANG N,NI S,et al.Pretreatment of lipopolysaccharide(LPS)ameliorates D-Gal N/LPS induced acute liver failure through TLR4 signaling pathway[J].Int J Clin Exp Pathol,2014,7(10):6626-6634. [5]MENG ZJ,ZHANG YH,LI WB,et al.Study of toll-like receptor(TLR)agonists on the inhibition of woodchuck hepatitis virus[J].Clin Hepatol,2013,18(6):378-381.(in Chinese)孟忠吉,张永红,李文兵,等.Toll样受体激动剂抑制土拨鼠肝炎病毒作用研究[J].肝脏,2013,18(6):378-381. [6]MA J,LIU H,WANG X.Effect of ginseng polysaccharides and dendritic cells on the balance of Th1/Th2 T helper cells in patients with non-small cell lung cancer[J].J Tradit Chin Med,2014,34(6):641-645. [7]LUCIFORA J,XIA Y,REISINGER F,et al.Specific and nonhepatotoxic degradation of nuclear hepatitis B virus ccc DNA[J].Science,2014,343(6176):1221-1228. [8]ISOGAWA M,ROBEK MD,FURUICHI Y,et al.Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J].J Virol,2005,79(11):7269-7272. [9]LU X,XU Q,BU X,et al.Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection[J].Int J Clin Exp Pathol,2014,7(9):6048-6055. [10]JOHN B,CRISPE IN.TLR-4 regulates CD8+T cell trapping in the liver[J].J Immunol,2005,175(3):1643-1650. [11]DADAGLIO G,FAYOLLE C,ZHANG X,et al.Antigen targeting to CD11b+dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+T cell responses[J].J Immunol,2014,193(4):1787-1798. [12]TACHE DE,STANCIULESCU CE,BANITA IM,et al.Inducible nitric oxide synthase expression(i NOS)in chronic viral hepatitis and its correlation with liver fibrosis[J].Rom J Morphol Embryol,2014,55(2 Suppl):539-543. [13]CHANG WW,SU IJ,LAI MD,et al.The role of inducible nitric oxide synthase in a murine acute hepatitis B virus(HBV)infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA[J].J Hepatol,2003,39(5):834-842. [14]ZHANG Y,LIAN JQ,HUANG CX,et al.Overexpression of Tolllike receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+)regulatory T cells in chronic hepatitis B virus infection[J].Virology,2010,397(1):34-42. [15]DU L,TIAN Y,LIU JS.The effects of HBs Ag on the expression of Toll like receptors in Raw264.7cells[J].Chin J Viral Dis,2013,3(1):51-54.(in Chinese)杜玲,田怡,刘建生.乙型肝炎表面抗原对RAW264.7细胞株Toll样受体表达模式的影响[J].中国病毒病杂志,2013,3(1):51-54. [16]ZI J,WANG Q,ZHENG L,et al.The effect of HBe Ag on TLR4expression in placenta of pregnant women with chronic hepatitis B[J].Chin J Birth Health Heredity,2010,18(4):41-43.(in Chinese)资捷,王前,郑磊,等.HBe Ag对慢性乙型肝炎孕妇胎盘组织TLR4表达的作用研究[J].中国优生与遗传杂志,2010,18(4):41-43. [17]RUAN P,YANG C,SU JJ,et al.Expressions and significance of TLR2 and TLR4 in Kupffer cells of tree shrews chronically infected with hepatitis B virus[J].Chin J Cell Mol Immunol,2014,30(7):686-690.(in Chinese)阮萍,杨春,苏建家,等.慢性乙型肝炎病毒感染树鼩Kupffer细胞TLR2和TLR4的表达及其意义[J].细胞与分子免疫学杂志,2014,30(7):686-690. [18]WAN YB,LI GQ,LI ZH.Expression of TLR2 and TLR4 in the serum of patients with hepatitis B and its clinical significance[J].Hainan Med J,2012,23(17):4-5.(in Chinese)万彦彬,李观强,李朝辉.乙型肝炎患者血清中TLR2和TLR4的表达及其意义[J].海南医学,2012,23(17):4-5. [19]PAN C,GU Y,ZHANG W,et al.Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure[J].PLo S One,2012,7(11):e49460. [20]LI WL,WU MS,HUANG YB,et al.The change of toll-like receptor 4 on peripheral blood mononuclear cells and the serum Thl/Th2 cytokine levels in patients with chronic hepatitis B receiving interferon-αtherapy[J].J Pract Hepatol,2012,15(4):315-317.(in Chinese)李文莉,吴茂盛,黄育波,等.α-干扰素治疗慢性乙型肝炎患者外周血单个核细胞TLR4表达和血清Th1/Th2型细胞因子的变化[J].实用肝脏病杂志,2012,15(4):315-317. [21]HERMOSO MA,MATSUGUCHI T,SMOAK K,et al.Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor2 gene expression[J].Mol Cell Biol,2004,24(11):4743-4756. [22]BRUN P,CASTAGLIUOLO I,PINZANI M,et al.Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells[J].Am J Physiol Gastrointest Liver Physiol,2005,289(3):g571-g578. [23]SHI H,DONG L,DANG X,et al.Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells[J].Inflamm Res,2013,62(6):581-587. [24]HU X,ZHANG K,XU C,et al.Anti-inflammatory effect of sodium butyrate preconditioning during myocardial ischemia/reperfusion[J].Exp Ther Med,2014,8(1):229-232. [25]SHEN XD,KE B,ZHAI Y,et al.Absence of toll-like receptor 4(TLR4)signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model[J].Liver Transpl,2007,13(10):1435-1443. [26]MCDONALD KA,HUANG H,TOHME S,et al.Toll-like receptor 4(TLR4)antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1(HMGB1)signaling[J].Mol Med,2015,20:639-648. -
![WeChat](/fileLCGDBZZ/journal/article/lcgdbzz/2016/3/WECHAT/wechat_cn_LCGD201603055.jpg)
计量
- 文章访问数: 1434
- HTML全文浏览量: 14
- PDF下载量: 319
- 被引次数: 0